Beta Wealth Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $656K | Sell |
5,916
-1,612
| -21% | -$179K | 0.24% | 51 |
|
|
2025
Q1 | $844K | Sell |
7,528
-95
| -1% | -$10.6K | 0.3% | 43 |
|
|
2024
Q4 | $704K | Buy |
7,623
+102
| +1% | +$9.42K | 0.31% | 50 |
|
|
2024
Q3 | $631K | Buy |
7,521
+802
| +12% | +$67.2K | 0.28% | 60 |
|
|
2024
Q2 | $47K | Buy |
6,719
+193
| +3% | +$1.35K | 0.02% | 102 |
|
|
2024
Q1 | $478K | Buy |
6,526
+216
| +3% | +$15.8K | 0.23% | 68 |
|
|
2023
Q4 | $511K | Sell |
6,310
-96
| -1% | -$7.78K | 0.27% | 60 |
|
|
2023
Q3 | $480K | Buy |
6,406
+105
| +2% | +$7.87K | 0.28% | 64 |
|
|
2023
Q2 | $486K | Buy |
6,301
+1,501
| +31% | +$116K | 0.28% | 63 |
|
|
2023
Q1 | $398K | Buy |
+4,800
| New | +$398K | 0.23% | 66 |
|
|
2022
Q4 | – | Sell |
-4,100
| Closed | -$252K | – | 99 |
|
|
2022
Q3 | $252K | Buy |
4,100
+200
| +5% | +$12.3K | 0.18% | 77 |
|
|
2022
Q2 | $241K | Buy |
3,900
+300
| +8% | +$18.5K | 0.16% | 75 |
|
|
2022
Q1 | $214K | Buy |
+3,600
| New | +$214K | 0.14% | 89 |
|